GE HealthCare has signed an agreement with Axim Life Isotopes South Africa (Pty) Ltd. (ALISA), a joint venture between Life Healthcare and the AXIM Group of Companies, to expand provision of molecular imaging in South Africa with the delivery of two Cyclotrons, which produce radioisotopes, enabling the production of tracing agents used in molecular imaging scans.
GE HealthCare will deliver the Cyclotrons to ALISA’s laboratory facility in Midrand, South Africa early next year, giving patients in Africa access to medical advancements. Molecular imaging enables doctors and clinicians to see inside the human body with a non-invasive process, helping to diagnose and treat diseases such as cancer, cardiovascular disease, and neurological diseases. It can allow early and precise diagnosis. It uses biomarkers to highlight molecular changes, which can sometimes alert doctors to possible diseases.
GE HealthCare General Manager, Eyong Ebai, Sub-Saharan Africa, said, “GE HealthCare is pleased to partner with ALISA, bringing together our global expertise in world-leading molecular imaging technology, with that of two market leaders, Life Healthcare and AXIM. This collaboration will drive continuous innovation in molecular imaging agent production, to improve access to radio-pharmaceuticals in South Africa, and help drive precision care in the region.”
ALISA is building on the established global collaboration in place between GE HealthCare and Life Healthcare.
More Stories
APP wins 22 out of 23 chairmanship seats in Rivers LG poll
Rivers LG poll: Jonathan warns political gladiators from disrupting democratic process
Fubara’s backed APP sweeps Rivers LG poll